- Home
- KROS vs AMBC Comparison
KROS vs AMBC Comparison
Compare KROS & AMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- AMBC
- Stock Information
- Founded
- KROS 2015
- AMBC 1991
- Country
- KROS United States
- AMBC United States
- Employees
- KROS N/A
- AMBC N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- AMBC Property-Casualty Insurers
- Sector
- KROS Health Care
- AMBC Finance
- Exchange
- KROS Nasdaq
- AMBC Nasdaq
- Market Cap
- KROS 460.6M
- AMBC 543.0M
- IPO Year
- KROS 2020
- AMBC 1991
- Fundamental
- Price
- KROS $11.00
- AMBC $11.51
- Analyst Decision
- KROS Buy
- AMBC Strong Buy
- Analyst Count
- KROS 11
- AMBC 2
- Target Price
- KROS $45.33
- AMBC $17.00
- AVG Volume (30 Days)
- KROS 2.1M
- AMBC 431.2K
- Earning Date
- KROS 02-26-2025
- AMBC 02-25-2025
- Dividend Yield
- KROS N/A
- AMBC N/A
- EPS Growth
- KROS N/A
- AMBC N/A
- EPS
- KROS N/A
- AMBC N/A
- Revenue
- KROS $651,000.00
- AMBC $398,000,000.00
- Revenue This Year
- KROS $303.27
- AMBC N/A
- Revenue Next Year
- KROS N/A
- AMBC N/A
- P/E Ratio
- KROS N/A
- AMBC N/A
- Revenue Growth
- KROS 8037.50
- AMBC 22.46
- 52 Week Low
- KROS $9.78
- AMBC $10.12
- 52 Week High
- KROS $73.00
- AMBC $18.45
- Technical
- Relative Strength Index (RSI)
- KROS 24.79
- AMBC 45.24
- Support Level
- KROS $11.04
- AMBC $11.35
- Resistance Level
- KROS $11.99
- AMBC $11.72
- Average True Range (ATR)
- KROS 0.60
- AMBC 0.31
- MACD
- KROS 1.20
- AMBC 0.05
- Stochastic Oscillator
- KROS 43.99
- AMBC 59.15
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About AMBC Ambac Financial Group Inc.
Ambac Financial Group Inc is a financial services holding company. The business operations of the company include Legacy Financial Guarantee Insurance, Specialty Property and Casualty Insurance and Insurance Distribution. The Company has three reportable segments namely Legacy Financial Guarantee Insurance, Specialty Property and Casualty Insurance and Insurance Distribution. Majority of revenues are earned from Legacy Financial Guarantee Insurance segment.